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Abstract
The development of secondary lymphoid organs, such as lymph nodes (LNs), in the embryo results
from the reciprocal action between lymphoid tissue inducer (LTi) cells and stromal cells. However,
the initial events inducing LN anlagen formation before the LTi stromal cells cross-talk interactions
take place are not fully elucidated. In this study, we show that the inguinal LN anlagen in mouse
embryos developed from mesenchymal cells surrounding the lymph sacs, spherical structures of
endothelial cells that bud from veins. Using inguinal and mesenteric LNs (mLNs), we provide
evidence supporting a two-step maturation model for stromal cells: first, ICAM-1−VCAM-1−
mesenchymal precursor cells become ICAM-1intVCAM-1int cells, in a process independent of LTi
cells and lymphotoxin β receptor (LTβR) signaling. The second step involves the maturation of
ICAM-1intVCAM-1int cells to ICAM-1highVCAM-1high mucosal addressin cell adhesion
molecule-1+ organizer cells and depends on both LTi cells and LTβR. Addition of αLTβR agonist
to LN organ cultures was sufficient to induce ICAM-1intVCAM-1int cells to mature. In LtβR−/−
embryos, both inguinal and mLN stromal cells showed a block at the ICAM-1intVCAM-1int stage,
and, contrary to inguinal LNs, mLNs persist longer and contained LTi cells, which correlated with
the sustained gene expression of Il-7, Cxcl13, and, to a lesser degree, Ccl21. Taken together, these
results highlight the importance of the signals and cellular interactions that induce the maturation of
stromal cells and ultimately lead to the formation of lymphoid tissues.
Lymph nodes (LNs) are specialized structures situated at strategic sites in the body along the
lymphatic vasculature network. They enable filtration of Ags and pathogens and provide a site
for Ag presentation to lymphocytes and induction of adaptive immune responses. LN
development is not fully elucidated, although several studies have reported on the role of
lymphoid tissue inducer (LTi) cells at late stages of LN formation. Recruitment of LTi cells
that express the TNF family molecule lymphotoxin α1β2 to the LN anlagen allows engagement
of lymphotoxin β receptor (LTβR)-expressing stromal cells. Subsequently, activation of two
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different pathways of the NF-κB transcription factor results in expression of high levels of
ICAM-1, VCAM-1, chemokines, and cytokines by the stromal cells (1–3). However, the early
events regulating LN anlagen formation remain unknown.
LN formation is tightly linked to the development of the lymphatic system and in particular to
the formation of lymph sacs. Although these events have been described a century ago, our
understanding is still limited. In 1902, Sabin (4,5) proposed that lymph sacs form from the
budding and sprouting of endothelial cells from veins. In contrast, Huntington and McClure
(6) suggested that lymph sacs develop from mesenchymal cells first, before venous endothelial
sprouting occurs from the newly formed lymph sacs. More recently, the use of markers specific
for lymphatic endothelial cells, such as VEGFR3 (7), Prox-1 (8), and the hyaluronic acid
receptor Lyve-1, showed that Lyve-1+Prox-1+ endothelial cells located in the anterior cardinal
vein bud around embryonic day (E) 10.5–11.5 to form a lymph sac under the guidance of
VEGFC signals (9). These data are in agreement with Sabin’s model (10), which suggested
that stromal cells derive from the lymph sac, which itself has an endothelial origin.
Interestingly, a recent report showed that Prox-1−/− mouse embryos failed to develop lymph
sacs, although they were still able to form primitive LN anlagen, indicating that endothelial
cells are not required to form the LN primordium and that the LN anlage derives from distinct
cell types (11).
We have previously reported on the isolation of inguinal LN (iLN) anlagen prior to the
recruitment of LTi cells (12). In this study, we report on the sequence of events leading to the
formation of iLN and mesenteric LN (mLN) anlagen in the mouse embryo. Our observations
indicate that iLN anlage develops at the site of interactions between the budding endothelium
and surrounding layers of mesenchymal cells that appear to invade the former. Combining
confocal microscopy and FACS analysis of E15 iLNs, we show the appearance of the very
first stromal cells coexpressing mesenchymal markers, like platelet-derived growth factor
receptor (PDGFR)α, and the stromal markers ICAM-1 or gp38/podoplanin. These cells,
characterized by their intermediate levels of expression of ICAM-1 and VCAM-1 (IintVint),
seem to give rise to ICAM-1highVCAM-1high (IhighVhigh) mucosal addressin cell adhesion
molecule-1 (MAdCAM-1)+ stromal organizer cells. This is supported by our findings using
an in vitro organ culture system with an agonistic anti-LTβR Ab. The stromal cell maturation
correlates with a gradual increase in mRNA levels of cytokine and chemokine genes. We also
show that LTβR and LTi cells are required for the IintVint cells to become IhighVhigh organizer
cells. Finally, our results demonstrate that in E17 LtβR−/− mLN, LTi cells are present and that
Cxcl13, Il-7, and lower levels of Ccl21 are still expressed, indicating that LTβR is not fully
necessary for the initial recruitment of LTi cells to the mLNs.
Our results indicate that lymphoid tissue stromal cells undergo a gradual maturation program
to create the proper milieu for recruitment of LTi cells followed by the generation of the specific
T and B cell areas in the mature organ.
Materials and Methods
Mice
BALB/c (H-2d), C57BL/6 (H-2b), LtβR−/− (H-2b) (13) (C57BL/6 background), and Rorγ−/−
(H-2b) (14) (C57BL/6 background) mice were bred and maintained under specific pathogen-
free conditions in the Biomedical Services Unit at the University of Birmingham (Birmingham,
U.K.) according to Home Office and local ethics committee regulations. Day of vaginal plug
detection was designated as E0.
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Isolation of LN stromal and CD45+ cells and mLN organ culture
iLNs and mLNs were isolated at the indicated embryonic stages by microdissection and were
disaggregated by incubation in 2.5 mg/ml collagenase/dispase (R&D Systems, Minneapolis,
MN) and 100 µg/ml DNase I (Sigma-Aldrich, St. Louis, MO) in RF10 media at 37°C to obtain
single-cell suspensions. In some experiments, freshly isolated mLNs were explanted in fetal
organ culture prepared as described (15) and treated with the agonistic anti-LTβR Ab (clone
4H8) at 2 µg/ml for 3 d (16,17).
Abs and flow cytometry
The following Abs were used for flow cytometry: CD45.2-FITC clone 104, ICAM-1–PE clone
YN1/1.7.4, VCAM-1–APC clone 429, MAdCAM-1–biotin clone MECA-367, VEGFR-3–
biotin clone AFLA4, PDGFR-α–APC clone APA5, (eBioscience, San Diego, CA), and gp38/
podoplanin 8.1.1 supernatant (hamster; kind gift from A. Farr, University of Washington,
Seattle, WA). Biotinylated Abs were detected using streptavidin-PECy5.5 (eBioscience).
gp38/podoplanin Ab was detected using goat anti-hamster– FITC (Southern Biotechnology
Associates, Birmingham, AL). All stainings were made in PBS plus 0.1% BSA, 10% mouse
serum, and 10% rat serum. Four-color flow cytometric analysis was performed using an
FACSCalibur (BD Biosciences, San Jose, CA) with forward/side scatter gates set to exclude
nonviable cells. Gates were applied appropriately according to the expression profile of the
molecules being assayed. Data were analyzed with FlowJo software (Tree Star, Ashland, OR).
Cell sorting, RT-PCR, real-time RT-PCR
Isolation of the different CD45− ICAM-1/VCAM-1 mLN stromal cell populations from wild-
type (WT) and LtβR−/− embryos of the indicated ages was performed by MoFlow
(DakoCytomation, Carpinteria, CA) cell sorting from disaggregated LN cell suspensions and
then snap frozen for RT-PCR.
High-purity cDNA was generated from purified mRNA using µMacs One-Step cDNA
synthesis kit, according to the manufacturer’s instructions (Miltenyi Biotec, Auburn, CA).
Real-time PCR was performed using IQ SYBR Green Supermix (Bio-Rad, Hercules, CA) with
primers specific for β-actin, Ccl21, Ccl19, Cxcl13, Il-7, LtβR, RelB, RankL, TnfrI, and
Mmp9. PCRs were conducted in triplicate in 10 µl volumes containing 200 nM primers. After
an initial denaturation step (95°C for 10 min), cycling was performed at 95°C for 15 s, 60°C
for 20 s, and 72°C for 5 s (45 cycles). Specific amplification was verified by melt curve analysis
and also by fractionation of PCR products on a 2% agarose gel that were identified by fragment
size (data not shown). mRNA transcript levels of each gene were analyzed using Applied
Biosystem’s SDS software (Applied Biosystems, Foster City, CA) by setting thresholds
determining the cycle number at which the threshold was reached (Ct). The Ct of the β-actin
was subtracted from the Ct of the target gene, and the relative amount was calculated as
2−ΔCt. Means of triplicate reactions (multiply 1000-fold) were represented, and data shown are
representative of at least two separate cell-sorting experiments. Primer sequences are shown
in Supplemental Fig. 1.
Immunofluorescence stainings
For tissue-section stainings, iLNs and mLNs were isolated and embedded in OCT compound
(Tissue Tek, Torrance, CA), then frozen in liquid nitrogen. Six-micrometer sections of tissue
were cut and fixed in acetone. Abs used were gp38/podoplanin 8.1.1, ICAM-1–FITC clone
YN1/1.7.4, PDGFRα clone APA5, CD44-FITC clone IM7, receptor activator for NF-κB ligand
(RANKL)-biotin clone IK22/5, MAdCAM-biotin clone MECA-367 (eBioscience), collagen
type I (Chemicon International, Temecula, CA), laminin α5 (rat; gift of A. Zapata, Complutense
University, Madrid, Spain) perlecan (rat; gift of Z. Lokmic, Bernard O’Brien Institute of
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Microsurgery, Melbourne, Australia), CCL21 (R&DSystems), Lyve-1 (rabbit polyclonal;
Abcam, Cambridge, MA), fibronectin clone FN-3E2 (mouse IgM; Sigma-Aldrich), ER-TR7
supernatant (Biogenesis, Poole, U.K.). CD4 was directly conjugated using the Alexa Fluor 647
mAb Labeling Kit (Invitrogen, Carlsbad,CA). ICAM-1–FITC-conjugated Ab was detected
using rabbit anti-FITC (Sigma-Aldrich), then goat anti-rabbit IgG-FITC (Jackson
ImmunoResearch Laboratories, West Grove, PA). Anti-PDGFRα was detected using anti-rat
IgG-Alexa 594 (Molecular Probes, Eugene, OR). Lyve-1 Ab was detected using goat anti-
rabbit IgG-FITC (Jackson ImmunoResearch Laboratories). Collagen type I Ab was detected
with goat anti-rabbit IgG-biotin (DakoCytomation). CCL21 Ab was detected using donkey
anti-goat FITC (Jackson ImmunoResearch Laboratories). gp38/podoplanin and fibronectin
Abs were detected using goat anti-hamster biotin (Cambridge Bioscience, Cambridge, U.K.).
Biotinylated Abs were detected using streptavidin-Alexa Fluor 555 or 488 (Molecular Probes).
Sections were mounted using Vectashield mounting medium (Vector Laboratories,
Burlingame, CA).
Image acquisition and analysis of confocal images
For tissue-section stainings, confocal images were acquired using a Zeiss LSM 510 laser
scanning confocal head with a Zeiss Axio Imager Z1 microscope (Zeiss, Oberkochen,
Germany). Digital images were recorded in four separately scanned channels with no overlap
in detection of emissions from the respective fluorochromes. Confocal micrographs were
stored as digital arrays of 2048 × 2048 pixels with 8-bit sensitivity; detectors were routinely
set so that intensities in each channel spanned the 0–255 scale optimally.
Results
Inguinal LN anlagen formed by budding endothelial cells surrounded by mesenchymal cells
Over the past few years, the structure of the developing LN anlagen in the mouse embryo had
been studied by assessing the recruitment and presence of LTi cells in sections of whole mouse
embryos (11,18–20). However, the iLN anlage forms a very distinct structure that can be
dissected as early as E13. Our previous studies have shown that E15 iLNs contain very few
CD45+ cells and no CD4+IL7Rα+ LTi cells (12). Therefore, experimental approaches relying
on the presence of LTi cells for the identification of LN anlagen do not allow for early detection
and analysis of LN primordium. For an in-depth analysis of LN anlage development prior to
LTi cell colonization, we examined sections of dissected E13 and E15 iLNs.
At E13, the primitive iLN anlage had a spherical shape formed by a bud of tightly packed gp38/
podoplanin+ cells surrounded by layers of fibroblast-like cells that expressed the component
of the reticular network ER-TR7 (Fig. 1A). We further characterized these two cellular
compartments for the expression of endothelial and mesenchymal markers on E15 iLNs
sections by immunofluorescence staining and confocal imaging.
The bud of gp38/podoplanin+ cells expressed the endothelial markers ICAM-1 and CCL21
and the extracellular matrix proteins collagen type I, and laminin α5 (Fig. 1B, left columns).
Perlecan staining was restricted to a thin layer at the interface between the endothelial and the
mesenchymal cells, indicating the presence of an intact basement membrane produced by the
former.
The fibroblast-like cells that formed the outer layers of the LN primordium expressed several
molecules characteristic of mesenchymal cells, such as PDGFRα, the extracellular matrix
protein fibronectin, ER-TR7, and the hyaluronic acid receptor CD44 (Fig. 1B, right
columns).
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Staining of iLN sections demonstrated that ER-TR7+ stromal cells and the gp38/
podoplanin+ lymphatic endothelial cell compartment remained separated up to E16, and then
ER-TR7+ cells appeared to invade the endothelial core to form the proper internal
compartments of the anlage (Fig. 2, Supplemental Fig. 2). Following that process, a large
number of mesenchymal cells at E17 expressed both ER-TR7 and gp38/podoplanin and could
be distinguished from the single-positive cells (Supplemental Fig. 2).
Based on the above observations, we envision the structure of the E13–15 iLN anlagen
comprising two distinct cells types, a bud of lymphatic endothelial cells forming the lymph
sacs, surrounded by a basement membrane and layers of mesenchymal cells.
Ongoing remodeling of the iLN anlage structure between E15 and E17
To further define the organ remodeling taking place between E15 and E17 in iLNs, we tracked
the changes occurring in the mesenchymal and endothelial compartments by analyzing E17
iLNs, when LTi cells arrived to the anlagen. Immunofluorescence staining of molecules
expressed in endothelial and mesenchymal cells were performed in E17 iLN sections and
compared with the stainings of these organs at E15.
The endothelial cells that formed a central bud at E15 still form the core of the anlagen at E17
(Fig 2, circled by a white line), but now contained perlecan+ laminin α5+ structures that form
the LN vasculature (Fig. 2A, 2D).
The mesenchymal cells formed the outer structure of the LN anlage, similar to what was
observed at E15. However, at E17, mesenchymal cells expressing fibronectin and PDGFRα
started to migrate to the endothelial core, as shown in the central region delimitating the
endothelium (Fig. 2C–H). CD44 staining (Fig. 2I) highlighted the structure of the mesenchymal
compartment as well as hematopoietic cells (round cells) that have entered the LN anlagen.
Fibronectin also started to be expressed by cells of the vasculature (Fig. 2C, 2E, arrowheads).
Taken together, these observations show the dynamic changes occurring between E15 and E17
in the iLN anlagen involving both the endothelium and the mesenchyme. For the endothelium,
the most dramatic change consisted of the remodeling of the whole vasculature and for the
mesenchyme of the invasion of the central endothelial compartment. We further characterize
the endothelial and mesenchymal cell populations to better understand their contribution to LN
anlagen formation.
Concomitant emergence of stromal organizer cells during remodeling of the iLN structure
The LN organizer cells have been previously characterized by their coexpression of ICAM-1
and VCAM-1 on mLNs, and the stainings suggested a differentiation of the organizer cells
from mesenchymal cells (18,21,22). We assessed by FACS analysis the presence of these cells
at different stages of embryonic iLN development. At E15, we were able to clearly identify
the mesenchymal and endothelial cell compartments described in Fig. 1: 1) the mesenchymal
cell precursors that were negative for ICAM-1 andVCAM-1(I−V−) and PDGFRα+ that
correlated with the fibroblast-like cells of the surrounding mesenchyme in Fig. 1B; and 2) the
ICAM-1 singlepositive (I+V−) endothelial cells that also expressed gp38/podoplanin and
MAdCAM-1 and were VEGFR3−, similar to the central endothelium shown in Fig. 1B (Fig.
3A, top panels). Interestingly, we identified a third cell population that expressed intermediate
levels of ICAM-1 and VCAM-1 (IintVint) that were PDGFRα+ and gp38/podoplanin+,
suggesting that they derived from the I−V− mesenchymal cells. At E17, the mature stromal
organizer cells were identified by their high expression of ICAM-1 and VCAM-1
(IhighVhigh) as well as MAdCAM-1, a late differentiation marker. Mature organizer cells also
expressed PDGFRα and gp38/podoplanin but not VEGFR3, suggesting that their progenitors
were the IintVint cell population.
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The I+V− endothelial cell population was negative for both VEGFR-3 and the lymphatic marker
Lyve-1 at E15 but became positive for both molecules at E17, indicating an ongoing
differentiation process toward lymphatic endothelial cells (Fig. 3A, bottom panels, and data
not shown). These results indicate that mesenchymal cells start to mature before the lymphatic
endothelium is fully differentiated.
To summarize, vascular/lymphatic endothelial cells could be defined as I+V− gp38/
podoplanin+ VEGFR3+ PDGFRα−, whereas the mesenchymal cell compartment encompassed
the I−V−, IintVint, and IhighVhigh MAdCAM-1+ gp38/podoplanin+ PDGFRα+ VEGFR3− cells.
Stromal cells of the iLN and mLN followed a similar pattern of development
Blocking of LTβR in pregnant female mice has shown that mLNs are the first to develop in
the embryos and are followed by formation of LNs from head to tail (1,23,24). Several reports
have indicated the different developmental requirements for mLN and iLN formation (25–
27). A recent report has also shown differences in the stromal cell subsets in these organs in
newborn mice (18), and we wanted to investigate whether those differences were already
present in embryos and whether mLN stromal cells expressed similar molecules than their iLN
counterparts. Indeed, E15 mLN showed an increased frequency of the IintVint cell population,
explained by the earlier development of the mLN anlage compared with iLN. However, the
same three compartments were still identifiable: 1) mesenchymal cells that were I−V−; 2)
IintVint cells; and 3) I+V− endothelial cells that also expressed MAdCAM-1 (Fig. 2B, top
panel). At E17, the mature stromal organizer cells IhighVhigh were present expressing
MAdCAM-1, as well as the I−V− mesenchymal and the IintVint cells. However, the I+V−
endothelial cells were not clearly identifiable in the mLNs at this stage (Fig. 3B).
Cellular localization and expression of different molecules were assessed by
immunofluorescence staining in E18 iLNs and mLNs. Both organs showed the presence of
CD4+IL-7Rα+ LTi cells as well as stromal organizer cells that expressed RANKL and
MAdCAM-1 (Fig. 4). Some lymphatic endothelial cells in the developing subcapsular sinus
surrounding the E18 mLNs and iLNs coexpressed MAdCAM-1 and Lyve-1, showing no
difference in the presence and structure of the lymphatic endothelium between iLN and mLN
(Fig. 4, middle panels). Thus, the absence of an I+V− endothelial cell population in E17 mLNs
compared with iLNs might be due to the stripping of the mLN capsule during dissection of the
organs prior to FACS analysis (Fig. 3A, 3B).
Gradient of gene expression of stromal organizer markers during maturation of the
mesenchyme
To confirm the sequence of maturation of the mesenchyme, we assessed the mRNA levels of
several genes that are characteristic of stromal cells. The small number of cells present in
embryonic iLNs prevented a more in-depth analysis. To have a significant number of stromal
cells for these assays, CD45− cell populations (I−V−, IintVint, and IhighVhigh) were isolated from
E18 mLNs, and the gene expression profile was analyzed by quantitative PCR (qPCR).
The expression of most of the genes analyzed was nil in I−V− cells with the exception of Tnf-
R1 and Ccl21. All CD45− cells expressed LtβR, but only the differentiating IintVint and
IhighVhigh cells expressed RelB. The IhighVhigh stromal organizer cells expressed the highest
levels of homeostatic chemokines (Ccl21, Ccl19, and Cxcl13) (18), RankL and Il-7, confirming
their potential to attract and stimulate LTi cells (Fig. 5). The IintVint and IhighVhigh cells
expressed Mmp9, which has been shown to increase cellular invasiveness and mobility,
indicating a role in tissue remodeling by these cell subsets. Finally, we noticed that all the
markers studied showed a gradient of expression, with the IhighVhigh cells showing the highest
Bénézech et al. Page 6
J Immunol. Author manuscript; available in PMC 2011 April 15.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
levels, followed by IintVint and I−V− that reflected the stage of maturation of the stroma (Fig.
5).
Absence of LtβR or LTi cells resulted in a block of stromal cell maturation at the IintVint stage
LN development is strictly dependent on LTi cells and LTβR signaling, as adult Rorγ−/−,
LtβR−/−, and Ltα−/− mice lack all LNs (13,14,26,28,29). We assessed whether LTβR signaling
and LTi cells were required for the initial step of stromal cell maturation or for full progression
of these cells to the IhighVhigh stage. FACS analysis of stromal cell populations from E15 iLN
and mLN anlagen from WT, LtβR−/−, and Rorγ −/− embryos showed the emergence of the
IintVint cells in all strains (Fig. 6A). However, at E17, the iLNs were difficult to find in both
LtβR−/− and Rorγ−/− embryos, and what remained had the appearance of fibrous structures
(data not shown). FACS analysis of the few iLNs isolated from these mutants confirmed the
absence of the IhighVhigh mature stromal organizer cells in both strains (Fig. 6A).
We next investigated whether mLNs were similarly affected in their development as iLNs in
these mutants. In contrast to the low numbers of iLNs found in E17 LtβR−/− or Rorγ −/− mice,
mLNs were present in normal numbers in embryos from these strains. However, FACS analysis
of stromal cells revealed a similar block on the progression from IintVint to IhighVhigh mature
organizer cells (Fig. 6A).
Recruitment of CD45+ cells to iLNs and mLNs between E15 and E17 was impaired in
LtβR−/− and Rorγ−/− embryos. For example, in WT iLNs, we observed an 18-fold increase in
the recruitment of CD45+ cells between E15 and E17 and only a 1.6- and a 6-fold increase in
iLNs from LtβR−/− and Rorγ−/− embryos, respectively (Fig. 6A).
Our analyses showed that LTβR engagement and the presence of LTi cells were required for
the appearance of the IhighVhigh mature organizer cells but not for progression of mesenchymal
cells from I−V− toward the IintVint compartment.
LTβR-induced maturation of stromal cells from IintVint to IhighVhigh
We next tested whether the IintVint stromal cells were the precursors of the IhighVhigh organizer
cells. E14 mLNs and E15 iLNs were stimulated in organ cultures with an agonistic αLTβR Ab
and the ICAM-1 and VCAM-1 expression profiles of the CD45− cell populations were assessed
by FACS analysis. As shown in Fig. 6B, a significant increase in the frequency of IhighVhigh
cells was detected. Of note, E14 mLNs and E15 iLNs contained very few if any IhighVhigh cells,
suggesting that LTβR stimulation induced either those few cells to proliferate or the IintVint
cells to mature, becoming IhighVhigh organizer cells. Cell counts prior to and after LTβR
stimulation in organ cultures demonstrated no increase in cell numbers (data not shown). These
results strongly suggest that the IintVint cell population gives origin to IhighVhigh organizer cells
and that signaling through the LTβR was necessary and sufficient to induce the maturation.
LTβR is not fully required for the recruitment retention of LTi cells to mLNs
The accumulation of LTi cells in the LN anlagen may result from active recruitment of these
cells or proliferation of LTi cells or their precursors. A previous report showed that proliferation
of hematopoietic cells was very rare in LN anlagen, indicating that recruitment of LTi cells
and their precursors might be the dominant mechanism (19). IL-7Rα and CXCL13 (ligand of
CXCR5 expressed by LTi cells) have been shown to play an important role in the recruitment
of LTi cells, and IL-7 is thought to be an early localization signal, as late blockade of this
cytokine had minor effects on LTi cell migration and LN development (19).
Cell sorting of mLN cells from E15 WT and LtβR−/− embryos and qPCR were used to assess
the effect of LTβR deficiency in stromal cell production of chemokines and survival factors
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for LTi cells. Cxcl13 and Il-7 were expressed at similar levels by the IintVint cells in both WT
and LtβR−/− cells. We also noted that Ccl21 was mainly expressed by the I+V− endothelial
cells, and its expression was reduced but still present in LtβR−/− E15 mLN cells (Fig. 7A) (2).
The presence of LTi cells was assessed in E17 iLNs and mLNs from WT and LtβR−/− embryos.
A very low percentage of both CD45+ cells and LTi cells was present in LtβR−/− iLNs when
compared with WT (Fig. 7B). Interestingly, whereas the percentage of CD45+ cells was reduced
in LtβR−/− compared with WT E17 mLNs, a similar frequency of LTi cells was found in both
strains, corroborating previous findings in E16.5 Ltα−/− embryos (19). Staining of sections of
E16 mLNs from WT and LtβR−/− embryos confirmed the presence of LTi cells in both strains
and showed a significant reduction in MAdCAM-1 and undetectable levels of RANKL in the
latter (Fig. 7C).
These results showed that although overall colonization by CD45+ cells is reduced in the mLNs
of LtβR−/− embryos, LTi cells are still being recruited, suggesting that LTβR signals are not
fully required. However, MAdCAM-1 and RANKL levels are severely reduced in these organs,
showing their dependence on the LTβR pathway. Based on the results shown above we propose
a specific role for LTβR signaling in stromal cells during maturation (Fig. 8, see Discussion).
Discussion
The majority of LN development studies have used whole mount sections of mouse embryos
and relied on the accumulation of LTi cells for the identification of LN primordium (11,18–
20). Therefore, little is known about the initiating events that take place before the recruitment/
arrival of LTi cells to the LN anlage. We took advantage of the well-defined structure of the
early iLN and performed microdissection of intact anlage to show that the LN primordium
developed where endothelial cells formed a spherical body, the lymph sac. This endothelium
is surrounded by a perlecan+ basement membrane and expressed gp38/podoplanin, ICAM-1,
and CCL21. Expression of Lyve-1 and VEGFR3 was not detected by immunofluorescence
staining at E13 and appeared around E17 indicating an undergoing differentiation process
toward lymphatic phenotype. Based on these observations, we confirmed Sabin’s findings
(4,5) using pig embryos in that LN anlagen formed at sites of endothelial cell budding from
veins to form the primitive lymph sacs.
We showed that layers of mesenchymal cells surround the iLN endothelial bud and that
mesenchyme and endothelium remained two distinct compartments until E17, when
mesenchymal cells started to invade the former. Remodeling of the iLN anlage is concomitant
with the differentiation of the lymphatic endothelium and the recruitment of LTi cells that
induce the maturation of stromal cells to become proper organizer cells. Therefore, all these
essential milestones of iLN organogenesis appear to take place in a short length of time. The
signals that induce the mesenchymal cells to degrade the basement membrane and invade the
lymph sacs and whether endothelial-mesenchymal cell cross-talk interactions are important
for this process and for the differentiation of the lymphatic endothelium remain to be
investigated.
To understand the maturation process of the mesenchymal cell populations and their
contribution to the formation of the LN anlagen stroma, we tracked the emergence of the
IhighVhigh mature organizer cells by FACS analyses. E15 iLNs, that appear to lack LTi cells,
do contain IintVintPDGFRα+ cells suggesting that the latter are derived from the PDGFRα+
mesenchymal cell layers that surround the lymph sacs. In this regard, a recent report has shown
that lymph sacs are not required for the initiation of LN anlagen development (11), suggesting
that stromal cell differentiation does not depend on the endothelium and can take place in its
absence. In addition, we suggest that the IintVint gp38/podoplanin+ cell population will give
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rise to the mature IhighVhigh MAdCAM-1+ stromal organizer cells. The common expression
of PDGFRα by I−V−, IintVint, and IhighVhigh cells and gp38/podoplanin by IintVint and
IhighVhigh cells but not VEGFR3 suggested a precursor-product relationship between them.
iLN and mLN anlagen develop at different times during embryogenesis, have different
developmental requirement, and contain different frequencies of IintVint stromal cells. As
shown before in newborn mice, embryonic mLNs have a higher percentage of IintVint stromal
cells than iLNs but that does not reflect in a larger proportion of IhighVhigh organizer cells
because the latter is lower in mLNs than iLNs (Fig. 3A, 3B,Fig. 6A) (18). However, the sequence
of stromal cell maturation is similar in both LNs.
Although several reports had demonstrated that LN development is strictly dependent on LTi
cells and LTβR signaling as adult Rorγ−/−, LtβR−/−, and Ltα−/− mice lack most LNs, the fate
of the developing LN anlagen in those mutants had not been characterized (13,14,26,28,29).
Other groups and ours (11,12,19) have indicated that two different signals are required for
stromal organizer cell maturation. We have shown previously that in the absence of
lymphotoxin α and hence lymphotoxin α1β2, the maturation of stromal cells was blocked at
the IintVint stage (12). However, a role for LTβR engagement by ligands other than lymphotoxin
α1β2 to induce the transition of I−V− mesenchymal cells to the IintVint stage could not be ruled
out. Analysis of the LtβR−/− LNs showed that this receptor does not have a role in the first step
of stromal cell maturation. Thus, the signal(s) for the initial step of stromal cell maturation
remains elusive. Lymphotoxin α and LTβR engagement and the presence of LTi cells were
required for the second step of this process, for LtβR−/− and Rorγ−/− mouse embryos showed
normal development of iLNs and mLNs up to E15 but stromal cell maturation did not progress
further than the IintVint stage, and iLNs quickly regressed. Stimulation of E14 mLNs through
LTβR induced a strong increase in the frequency of IhighVhigh MAdCAM-1+ stromal organizer
cells that seems to be independent of cell proliferation. Similar results were obtained upon
LTβR stimulation of E15 iLNs, although upregulation of MAdCAM-1 expression was lower
than in mLN stromal cells. Taken together, these results support the hypothesis of a precursor-
product relationship between the IintVint cells and the IhighVhigh MAdCAM-1+ stromal
organizer cells.
We investigated the gene expression profile of three CD45− cell populations from E18 mLNs,
I−V−, IintVint, and IhighVhigh. Our results showed that although I−V− mesenchymal precursors
cells expressed LtβR mRNA, one of its downstream effectors, the transcription factor Relb,
was expressed only in the maturing IintVint and IhighVhigh cells. This finding suggests that the
first step of stromal cell maturation enables the LN anlagen to respond to LTβR signaling by
inducing the expression of the downstream proteins of this cascade. In agreement with this,
RankL was expressed at 1000-fold higher levels in the IhighVhigh cell population than in the
IintVint cells. Concomitantly, mLNs from E16.5 LtβR-deficient embryos, whose stromal cells
are blocked at the IintVint cell stage, showed no expression of RANKL. In contrast, Ccl21,
Cxcl13, and Il-7 were expressed in both IintVint and IhighVhigh cell populations, indicating that
these genes are less dependent on LTβR engagement for their full expression. In agreement
with this, the mRNA levels of Cxcl13 and Il-7 were not decreased in E15 mLN of LtβR-deficient
embryos. Ccl21 expression was significantly decreased in endothelial cells correlating with
previous reports on the expression of CCL21 by endothelial cells of high endothelial venules
and the role of LTβR–NF-κB2 in the latter (30–34). These results are in agreement with the
findings of Moyron-Quiroz and colleagues (35) showing that CXCL13 and CCL21 were
expressed independently of lymphotoxin α during the formation of inducible bronchial-
associated lymphoid tissues. A recent report has indicated that retinoic acid expressed by
neurons induces the expression of Cxcl13 in LN anlagen independently of LTβR signaling
(36).
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At E17 when iLNs from LtβR−/− mice have regressed, mLNs were still present in this mutant
but showed a failure to induce RANKL and MAdCAM-1 in stromal cells compared with WT
mLNs, highlighting the importance of LTβR signaling for the expression of these molecules
(20). The absence of RANKL expression in the LtβR−/− mLN may compromise the survival
of LTi cells, which may be dependent on RANK signaling, as suggested by the reduced number
of these cells found in the mLNs of newborn mice deficient in this pathway or the intracellular
adaptor TNFR-associated factor-6 as well as in embryos treated with RANK-Ig fusion protein
(19,37,38). These findings correlate with the fact that rudimentary mLNs have been found in
newborn LtβR−/− mice.
Based on the results shown in this study, we propose a two-step stromal cell maturation model
(Fig. 8). First, the I−V− mesenchymal cells are primed by a yet unknown signal to give rise to
an IintVint gp38/podoplanin+ cell population, able to recruit LTi cells by their expression of
Il-7, Ccl21, and Cxcl13 and to respond to LTβR engagement via acquisition of the expression
of RelB. Second, the IintVint cells gave rise to the mature IhighVhigh MAdCAM-1+ stromal
organizer cells. Following these essential maturation steps during embryogenesis, LN stromal
cells require stimulation by IL-7Rα+ cells at the time of birth to sustain LN development and
organization (39).
It is clear that stromal cell function in lymphoid tissues is more than contributing a support for
the exquisite architecture of these organs. Stromal cells also have a role in B and T cell
homeostasis as well as in the organization of specific cell areas to facilitate the localization
and interaction of cells during immune responses (40,41). All these functions suggest the
existence of different subsets of stromal cells, and further studies will be necessary to
investigate the ontogeny of fibroblastic reticular cells and marginal reticular cells (42–45). We
are currently investigating the origin of the I−V− mesenchymal cell precursors, the signals that
induce priming on those cells to become IintVint and the role for the recently described lymphoid
tissue initiator cells have in this process (46).
The process of maturation of lymphoid tissue stromal cells might have similarities with the
recently described changes in the stromal microenvironment resulting in the differentiation of
lymphoid stromal cells during the formation of ectopic lymphoid tissues (47).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Acknowledgments
We thank the personnel in Biomedical Services Unit for taking good care of our animal colonies; Eric Jenkinson for
continuing support; and the Anderson and Lane Laboratories, Elodie Mohr, Guillaume Desanti, and Dave Withers for
helpful discussions and comments on the manuscript. We also thank Dan Littman and Daniela Finke for providing
the Rorγ−/− mice and Roger Bird for cell sorting.
This work was supported by a Biotechnology and Biological Sciences Research Council project grant (to J.H.C. and
G.A). Work in the laboratory of C.F.W. was supported by National Institutes of Health Grant AI33068. E.M. is the
recipient of a Medical Research Council Doctoral Training Account Ph.D. studentship.
Abbreviations used in this paper
Ct cycle threshold
E embryonic day
iLN inguinal lymph node
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I−V− negative for ICAM-1 and VCAM-1
I+V− ICAM-1 single-positive
IhighVhigh high expression of ICAM-1 and VCAM-1
IintVint intermediate levels of ICAM-1 and VCAM-1
LN lymph node
LTβR lymphotoxin β receptor
LTi lymphoid tissue inducer
MAdCAM-1 mucosal addressin cell adhesion molecule-1
mLN mesenteric lymph node
NA numerical aperture
PDGFR platelet-derived growth factor receptor
qPCR quantitative PCR
RANKL receptor activator for NF-κB ligand
WT wild-type
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FIGURE 1.
The LN anlagen developed at the site of contact between mesenchymal and endothelial cell
populations. A, Structure of an E13 iLN primordium. At this stage, the iLN primordium consists
of a bud of endothelial cells stained with gp38/podoplanin (green) surrounded by layers of
mesenchymal cells stained with ER-TR7 (red) (×40/1.4 numerical aperture [NA] water lens).
B, Immunofluorescence staining of E15 iLN sections (×40/1.4NAwater lens) showing the
central endothelium stained with gp38/ podoplanin, ICAM-1, CCL21 (green), collagen type I
(red), laminin α5 (green), and perlecan (red) and the surrounding mesenchyme stained with
PDGFRα, fibronectin, ER-TR7 (red), and CD44 (green). The left panels of all sections show
the overlay with DAPI (white) staining the cell nuclei.
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FIGURE 2.
Mesenchymal cells invade the endothelial bud around E17 in iLNs. Immunofluorescence
stainings of E17 iLN sections (×25/1.4 NA water lens) showing the endothelial markers
perlecan in green (A), collagen type I in red, (B, F, H, and J), and laminin α5 in red (D). The
following molecules expressed by mesenchymal cells have been stained in green: PDGFRα
(G), fibronectin (C and E), and CD44 (I). Note that fibronectin also stained some cells of the
vasculature and CD44 also stained hematopoietic cells. A white line has been drawn encircling
the endothelial cell compartment. The bottom row shows the DAPI (white) staining the cell
nuclei. Scale bar, 50 µm (A).
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FIGURE 3.
Ontogeny of stromal organizer cells. Emergence of the IhighVhigh stromal organizer cells in
LNs. FACS analysis of single-cell suspensions of iLN at E15 and E17 showing the recruitment
of CD45+ hematopoietic cells and the concomitant phenotypic changes in the CD45− stromal
cells. Percentages shown in histogram correspond to CD45− stromal cells and CD45+
hematopoietic cells. A, In iLNs, four different stromal cell populations were distinguished
according to their level of expression of ICAM-1 and VCAM-1, and the levels of PDGFRα,
gp38/podoplanin, MAdCAM-1, and VEGFR3 are shown for each stromal population: I−V−
(black) expressed PDGFRα, IintVint (blue) expressed gp38/podoplanin and PDGFRα, I+V−
(gray) expressed gp38/podoplanin, MAdCAM-1, and VEGFR-3 (E15 and E17), and
IhighVhigh (red) expressed PDGFRα, gp38/podoplanin, and MAdCAM-1 (E17). The ICAM-1/
VCAM-1 expression profile of the CD45− cells from iLNs changed between E15 and E17
independently of whether cells were harvested and analyzed on the same day or in different
days. The gates in A have been set up to fit according to the profile of the different ICAM and
VCAM expression levels in the cell populations rather than using the same for both E15 and
E17. B, In mLNs, the same four stromal cell populations were identified. The I+V− (gray) and
IhighVhigh (red) expressed MAdCAM-1 (E15 and E17). Percentages shown in scatter plots
correspond to CD45− stromal cells according to their expression of ICAM-1 and VCAM-1.
Results are representative of at least three independent experiments.
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FIGURE 4.
Structures of E18 mLN and iLN. Immunofluorescence staining of E18 mLN sections (×25/1.4
NA and ×40/1.4 NA water lens) and E18 iLN sections (×40/1.4 NA water lens) showing the
Lyve-1+ capsule (green), the CD4+ LTi cells (blue), and RANKL (top row), MAdCAM-1
(middle row), or IL-7Rα (bottom row) (red). Results are representative of at least three
independent experiments.
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FIGURE 5.
Gradient of expression of stromal organizer markers during maturation of the mesenchyme.
Cell sorting and gene expression analysis of E18 mLN I−V− (black), IlowVlow (blue), and
IhighVhigh (red) stromal cell populations. Real-time RT-PCR analysis of LtβR, RelB, Ccl21,
Ccl19, Cxcl13, Il-7, RankL, Mmp9, and Tnfr1 genes. Ratio of gene of interest to β-actin is
shown. Results are representative of at least three independent experiments.
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FIGURE 6.
LtβR signaling induce maturation of stromal cells from IintVint to IhighVhigh. A, FACS analysis
of single-cell suspensions from WT, LtβR−/−, and Rorγ−/− E15 and E17 iLNs and mLNs
showing the recruitment of CD45+ cells and the concomitant phenotypic changes in the
CD45− stromal cells. Percentages shown in histograms correspond to CD45− stromal cells and
CD45+ hematopoietic cells. The different ICAM-1 and VCAM-1 CD45− stromal cell
populations described in Fig. 3 are shown with corresponding percentages. Note the normal
development of the LtβR−/− and Rorγ−/− E15 iLN and the absence of the IhighVhigh stromal cell
populations in the LtβR−/− and Rorγ−/− E15 mLNs and E17 iLNs and mLNs. Results are
representative of at least three independent experiments. B, LTβR stimulation induces the
maturation of stromal cells from IintVint to IhighVhigh in E14 mLN and E15 iLN organ cultures.
FACS analysis of single-cell suspensions of E14 mLNs (left panels) and E15 iLNs (right
panels) in organ cultures for 3 d showing the phenotypic changes in the CD45− stromal cells
induced by agonistic αLTβR Ab (bottom panels). Percentages shown in histograms correspond
to CD45− stromal cells. Three different stromal cells populations were identified: I−V− (black),
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IintVint (blue), and IhighVhigh (red). Expression levels of MAdCAM-1 for each cell population
are shown in histograms. Results are representative of three independent experiments.
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FIGURE 7.
LTβR is not fully required for the recruitment and retention of LTi cells to mesenteric LNs.
A, Cell sorting and gene expression analysis of the WT and LtβR−/− E15 mLN I−V− (black),
IintVint (blue), and I+V− (gray) stromal cell populations. Real-time RT-PCR analysis of the
Ccl21, Il-7, and Cxcl13 genes. Ratio of gene of interest to β-actin is shown. Results are
representative of two independent experiments. B, LTβR is required for the recruitment of LTi
cells to iLNs but not mLNs. FACS analysis of single-cell suspensions from WT and LtβR−/−
E15 and E17 iLNs and mLNs showing the percentage of CD45+ cells and CD4+IL-7Rα+ LTi
cells. Percentages shown in histograms correspond to CD45+ hematopoietic cells. CD45+
hematopoietic cell dot plot analysis of CD4 and IL-7Rα showed the percentages of LTi cells.
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Note the presence of LTi cells in the LtβR−/− E17 mLN and their absence in iLNs. C,
Immunofluorescence staining of WT and LtβR−/− E16 mLN sections (×40/1.4 NA water lens)
showing the Lyve-1+ capsule (green), CD4+ LTi cells (blue), and in red, IL-7Rα (left panels),
MAdCAM-1 (middle panels), or RANKL (right panels). Note in the LtβR−/− mLNs the
presence of the capsule expressing Lyve-1 and MAdCAM-1, the presence of LTi cells
coexpressing IL-7Rα and CD4, and the absence of RANKL expression. Results are
representative of two independent experiments.
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FIGURE 8.
Model of LN stromal cell maturation. Based on our immunfluorescence and FACS analysis
data (summarized in the top row in capital letters) and qPCR data (summarized in the bottom
row in italics), we propose a model for the maturation of stromal cells during LN development.
The I−V− mesenchymal precursor cells (dark gray), upon stimulation by an unknown signal,
will become IintVint primed stromal cells (blue) that upon upregulating the expression of RelB
will be able to respond to LTβR signals upon engagement by the lymphotoxin α1β2 ligand
expressed by LTi cells. Signals through the LTβR and other receptors induce the maturation
of the IintVint cells (red) to become IhighVhigh stromal organizer cells (see Discussion).
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